Investing

Merck, Pfizer Weigh on DJIA Wednesday

Thinkstock

December 21, 2016: Markets opened mixed Wednesday and the consensus opinion seems to be that traders are pausing to think about whether they really want the DJIA to top 20,000. It’s really just a matter of time so if you haven’t already done so, get an office pool going. Leading sectors included energy and materials; laggards were healthcare and real estate. WTI crude oil for February delivery settled at $52.49 a barrel, down about 1.5% on the day. February gold dropped less than 0.1% on the day to settle at $1,133.20. Equities were headed for a lower close shortly before the bell as the DJIA traded down 0.08% for the day, the S&P 500 traded down 0.19%, and the Nasdaq Composite traded down 0.17%.

The DJIA stock posting the largest daily percentage loss ahead of the close Wednesday was Merck & Co. Inc. (NYSE: MRK) which traded down 1.66% at $59.49. The stock’s 52-week range is $47.97 to $65.46. Volume was about 10% below the daily average of around 10.8 million shares. The company had no specific news Wednesday.

Pfizer Inc. (NYSE: PFE) traded down 1.30% at $32.42. The stock’s 52-week range is $28.25 to $37.39. Volume was about 40% below the daily average of around 26.5 million shares. The company had no specific news.

The Goldman Sachs Group Inc. (NYSE: GS) traded down 0.63% at $241.57. The stock’s 52-week range is $138.20 to $245.57. Volume was about 30% below the daily average of around 3.9 million shares. The bank was fined $120 million by the Commodities Futures Trading Commission for manipulating interest rate products from 2007 to 2012.

Intel Corp. (NASDAQ: INTC) traded down 0.52% at $37.01. The stock’s 52-week range is $27.68 to $38.36. Volume was about 55% below the daily average of around 21.5 million shares. The semiconductor giant had no specific news.

Of the Dow 30 stocks, 9 are on track to close higher Wednesday and 22 are set to close lower.

Smart Investors Are Quietly Loading Up on These “Dividend Legends” (Sponsored)

If you want your portfolio to pay you cash like clockwork, it’s time to stop blindly following conventional wisdom like relying on Dividend Aristocrats. There’s a better option, and we want to show you. We’re offering a brand-new report on 2 stocks we believe offer the rare combination of a high dividend yield and significant stock appreciation upside. If you’re tired of feeling one step behind in this market, this free report is a must-read for you.

Click here to download your FREE copy of “2 Dividend Legends to Hold Forever” and start improving your portfolio today.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.